Impact of retroperitoneal lymph node dissection in ovarian cancer – time for paradigm shift?

References

[1] Kim HS, Ju W, Jee BC, Kim YB, Park NH, Song YS, et al. Systematic lymphadenectomy for survival in epithelial ovarian cancer. A meta-analysis. Int J Gynecol Cancer. 2010;20:520–8.10.1111/IGC.0b013e3181d6de1dSearch in Google Scholar PubMed

[2] Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14:9–32.10.20892/j.issn.2095-3941.2016.0084Search in Google Scholar PubMed PubMed Central

[3] Powless CA, Aletti GD, Bakkum-Gamez JM, Cliby WA. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol. 2011;122:536–40.10.1016/j.ygyno.2011.05.001Search in Google Scholar PubMed

[4] Meinhold-Heerlein I, Fotopoulou C, Harter P. Statement by the Kommission Ovar of the AGO: The New FIGO and WHO classifications of ovarian, fallopian tube and primary peritoneal cancer. Geburtshilfe Frauenheilkd. 2015;75:1021–7.10.1055/s-0035-1558079Search in Google Scholar PubMed PubMed Central

[5] Fleming GF, Seidman J, Yemelyanova A. Principles and practice of Gynecologic Oncology, 7^th ed. Philadelphia, PA: Wolters Kluwer Health, 2017.Search in Google Scholar

[6] Panici PB, Angioli R. Role of lymphadenectomy in ovarian cancer. Best Pract Res Clin Obstet Gynecol. 2002;16:529–51.10.1053/beog.2002.0301Search in Google Scholar PubMed

[7] Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Nat Cancer Institute. 2005;97:560–6.10.1093/jnci/dji102Search in Google Scholar PubMed

[8] Gao J, Yang X, Zhang Y. Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies. Japanese J Clin Oncol. 2015;45:49–60.10.1093/jjco/hyu175Search in Google Scholar PubMed

[9] Panici PB, Scambia G, Baiocchi G. Anatomical study of paraaortica and pelvic lymph nodes in gynecological malignancies. Obstet Gynecol. 1992;79:498–502.Search in Google Scholar

[10] Bogani G, Tagliabue E, Ditto A, Signorelli M, Martinelli F, Casarin J, et al. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: a predictors- and nomogram-based analyses. Gynecol Oncol. 2017;147:61–65.10.1016/j.ygyno.2017.07.139Search in Google Scholar PubMed

[11] Kleppe M, Wang T, Van Gorp T, Slangen BF, Kruse AJ, Kruitwagen RF. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011;123:610–14.10.1016/j.ygyno.2011.09.013Search in Google Scholar PubMed

[12] Minig L, Heitz F, Cibula D, Bakkum-Gamez JM, Germanova A, Dowdy SC, et al. Patterns of lymph node metastases in apparent stage I low-grade epithelial ovarian cancer: a multicenter study. Ann Surg Oncol. 2017;24:2720–6.10.1245/s10434-017-5919-ySearch in Google Scholar PubMed

[13] Lago V, Mining L, Fotopoulou C. Incidence of lymph node metastases in apparent early-stage low-grade epithelial ovarian cancer a comprehensive review. Int J Gynecol Cancer. 2016;26:1407–14.10.1097/IGC.0000000000000787Search in Google Scholar PubMed

[14] Iwase H, Takada T, Iitsuka C, Nomura H, Abe A, Taniguchi T, et al. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. J Gynecol Oncol. 2015;26:303–10.10.3802/jgo.2015.26.4.303Search in Google Scholar PubMed PubMed Central

[15] Harter P, Gnauert K, Hils R, Lehmann TG, Fisseler-Eckhoff A, Traut A, et al. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer. 2007;17:1238–44.10.1111/j.1525-1438.2007.00931.xSearch in Google Scholar PubMed

[16] Zhou J, Zhang W, Zhang QG, He ZY, Sun JY, Chen QH, et al. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: a population-based study. Int J Surg. 2018;52:11–15.10.1016/j.ijsu.2018.02.006Search in Google Scholar PubMed

[17] Pereira A, Perez-Medina T, Magrina JF, Magtibay PM, Rodriguez-Tapia A, de Leon J, et al. Correlation between the extent of intraperitoneal disease and nodal metastasis in node-positive ovarian cancer patients. EJSO. 2014;40:917–24.10.1016/j.ejso.2014.04.001Search in Google Scholar PubMed

[18] Mikami M. Role of lymphadenectomy for ovarian cancer. J Gynecol Oncol. 2014;25:279–81.10.3802/jgo.2014.25.4.279Search in Google Scholar PubMed PubMed Central

[19] Kleppe M, van der Aa MA, Von Gorp T, Slangen BF, Kruitwagen RF. The impact of lymph node dissection and adjuvant chemotherapy on survival: a nationwide cohort study of patients with clinical early-stage ovarian cancer. Eur J Cancer. 2016;66:83–90.10.1016/j.ejca.2016.07.015Search in Google Scholar PubMed

[20] du Bois A, Reuss A, Harter P, Pujade-Lauraine E, Ray-Coquard I, Pfisterer J. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. J Clin Oncol. 2010;28:1733–9.10.1200/JCO.2009.25.3617Search in Google Scholar PubMed

[21] Fagotti A, De Iaco P, Fanfani F, Vizzielli G, Perelli F, Pozzati F, et al. Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study. Ann Surg Oncol. 2012;19:3522–7.10.1245/s10434-012-2400-9Search in Google Scholar PubMed

[22] Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, et al. LION: lymphadenectomy in ovarian neoplasms – a prospective randomized AGO study group led gynecologic cancer intergroup trial. J Clin Oncol. 2017;35:5500.10.1200/JCO.2017.35.15_suppl.5500Search in Google Scholar